Association of anti-RNA polymerase III autoantibodies and cancer in scleroderma von Moinzadeh, Pia, Fonseca, Carmen, Hellmich, Martin, Shah, Ami A, Chighizola, Cecilia, Denton, Christopher P, Ong, Voon H

Volltext

Using Autoantibodies and Cutaneous Subset to Develop Outcome‐Based Disease Classification in Systemic Sclerosis von Nihtyanova, Svetlana I., Sari, Alper, Harvey, Jennifer C., Leslie, Anna, Derrett‐Smith, Emma C., Fonseca, Carmen, Ong, Voon H., Denton, Christopher P.

Volltext

Renal Disease and Systemic Sclerosis: an Update on Scleroderma Renal Crisis von Cole, Alice, Ong, Voon H., Denton, Christopher P.

Volltext

Prediction of Pulmonary Complications and Long‐Term Survival in Systemic Sclerosis von Nihtyanova, Svetlana I., Schreiber, Benjamin E., Ong, Voon H., Rosenberg, Daniel, Moinzadeh, Pia, Coghlan, J. Gerrard, Wells, Athol U., Denton, Christopher P.

Volltext

Clinical and pathological significance of interleukin 6 overexpression in systemic sclerosis von Khan, Korsa, Xu, Shiwen, Nihtyanova, Svetlana, Derrett-Smith, Emma, Abraham, David, Denton, Christopher P, Ong, Voon H

Volltext

Consensus best practice pathway of the UK Scleroderma Study Group: digital vasculopathy in systemic sclerosis von Hughes, Michael, Ong, Voon H, Anderson, Marina E, Hall, Frances, Moinzadeh, Pia, Griffiths, Bridget, Baildam, Eileen, Denton, Christopher P, Herrick, Ariane L

Volltext

Dynamic Prediction of Pulmonary Hypertension in Systemic Sclerosis Using Landmark Analysis von Nihtyanova, Svetlana I., Schreiber, Benjamin E., Ong, Voon H., Wells, Athol U., Coghlan, John G., Denton, Christopher P.

Volltext

The Use of Cyclosporine A in Rheumatology: a 2016 Comprehensive Review von Chighizola, Cecilia Beatrice, Ong, Voon H., Meroni, Pier Luigi

Volltext

Combinations of scleroderma hallmark autoantibodies associate with distinct clinical phenotypes von Clark, Kristina E. N., Campochiaro, Corrado, Host, Lauren V., Sari, Alper, Harvey, Jennifer, Denton, Christopher P., Ong, Voon H.

Volltext

Zibotentan in systemic sclerosis-associated chronic kidney disease: a phase II randomised placebo-controlled trial von Stern, Edward P, Host, Lauren V, Wanjiku, Ivy, Escott, K Jane, Gilmour, Peter S, Ochiel, Rachel, Unwin, Robert, Burns, Aine, Ong, Voon H, Cadiou, Helen, O'Keeffe, Aidan G, Denton, Christopher P

Volltext

BSR and BHPR guideline for the treatment of systemic sclerosis von Denton, Christopher P, Hughes, Michael, Gak, Nataliya, Vila, Josephine, Buch, Maya H, Chakravarty, Kuntal, Fligelstone, Kim, Gompels, Luke L, Griffiths, Bridget, Herrick, Ariane L, Pang, Jay, Parker, Louise, Redmond, Anthony, van Laar, Jacob, Warburton, Louise, Ong, Voon H

Volltext

Real-world experience of tocilizumab in systemic sclerosis: potential benefit on lung function for anti-topoisomerase-positive patients von Suleman, Yasir, Clark, Kristina E N, Cole, Alice R, Ong, Voon H, Denton, Christopher P

Volltext

Sustained benefit from intravenous immunoglobulin therapy for gastrointestinal involvement in systemic sclerosis von Raja, Jasmin, Nihtyanova, Svetlana I, Murray, Charles D, Denton, Christopher P, Ong, Voon H

Volltext

Absence of Clinically Meaningful Drug-Drug Interactions with Rezafungin: Outcome of Investigations von Flanagan, Shawn, Walker, Helen, Ong, Voon, Sandison, Taylor

Volltext

Diffuse cutaneous systemic sclerosis following SARS-Co V-2 vaccination von Cole, Alice, Thomas, Rhys, Goldman, Nina, Howell, Kevin, Chakravarty, Kuntal, Denton, Christopher P., Ong, Voon H.

Volltext

Dysregulated B cell function and disease pathogenesis in systemic sclerosis von Beesley, Claire F, Goldman, Nina R, Taher, Taher E, Denton, Christopher P, Abraham, David J, Mageed, Rizgar A, Ong, Voon H

Volltext

The Yin and Yang of IL-17 in Systemic Sclerosis von Wei, Lanxuan, Abraham, David, Ong, Voon

Volltext

Scleroderma mimics – Clinical features and management von Orteu, Catherine H., Ong, Voon H., Denton, Christopher P.

Volltext

Challenges in evidence-based therapy for systemic sclerosis associated interstitial lung disease von Denton, Christopher P, Ong, Voon H

Volltext

The pan-PPAR agonist lanifibranor reduces development of lung fibrosis and attenuates cardiorespiratory manifestations in a transgenic mouse model of systemic sclerosis von Derrett-Smith, Emma, Clark, Kristina E N, Shiwen, Xu, Abraham, David J, Hoyles, Rachel K, Lacombe, Olivier, Broqua, Pierre, Junien, Jean Louis, Konstantinova, Irena, Ong, Voon H, Denton, Christopher P

Volltext